Clinical trial
CrossBoss and Stingray Catheter and Entera Guidewire Chronic Total Occlusion (CTO) Study
NCT00801710 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CrossBoss and Stingray Catheter and Entera Guidewire Chronic Total Occlusion (CTO) Study
- Lead sponsor
- Boston Scientific Corporation
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 30, 2008
- Completion date
- September 30, 2009
- Enrollment
- 42 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
coronary artery chronic total occlusion, coronary artery disease